Intestinal Microflora in Lung Cancer After Chemotherapy
- Conditions
- Lung CancerEffects of ChemotherapyTumor ImmunityMalnutrition
- Interventions
- Drug: ProbioticsDrug: placebo
- Registration Number
- NCT02771470
- Lead Sponsor
- Shandong University
- Brief Summary
Probiotics modulate the gut microflora and immune status in lung cancer who need chemotherapy.
- Detailed Description
Chemotherapy destroys the intestinal mucosal barrier, affects intestinal flora, causing bacterial translocation, infection and other complications. Probiotics may restore the intestinal immunity, mucosal barrier and nutrient absorption.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 41
- Patients scheduled for chemotherapy of lung cancer
- Antibiotic, probiotic or prebiotic usage within 1month
- Other malignancy
- History of abdominal surgery
- Pregnant or breast-feeding (for females)
- Impaired liver or renal function
- Diabetes, thyroid disorder, coagulopathy or bleeding disorders, mental disorder
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Probiotic Probiotics Microbial composition using probiotics,3 capsules/times,3 times/day for 3 to 4 weeks Placebo placebo Microbiota modulation using probiotics,3 capsules/times,3 times/day for 3 to 4 weeks
- Primary Outcome Measures
Name Time Method Composition of Microorganisms in stool after probiotic intervention 2 months Primary coordination of fecal samples' 16s(%) rDNA will be compared between two groups using Braycurtis distance based Primary coordination analysis(PCoA)
- Secondary Outcome Measures
Name Time Method Frequency and severity of Adverse effects during Chemotherapy 2 months The change of immunity and nutrition index 2 months
Trial Locations
- Locations (1)
Department of Gastroenterology,Qilu Hospital,Shandong University
🇨🇳Jinan, Shandong, China